即时检验诊断技术在抗菌药物耐药性管理中的成本效果:一项系统综述
该研究系统检索2000至2023年文献,纳入20项评估即时检验(POCT)应对抗菌药物耐药性(AMR)的经济学评价。最常见的POCT针对呼吸道感染(n=10)、性传播感染(n=3)和中低收入国家发热患者(n=3)。18项研究显示POCT策略减少抗菌药物处方,其中10项在每避免一例抗菌药物处方的支付意愿阈值£33.80下具有成本效果。
要点
- 18项研究显示POCT策略减少抗菌药物处方,其中10项在£33.80/避免处方阈值下具成本效果。
- 最常见评估的POCT为呼吸道感染(n=10)、性传播感染(n=3)和中低收入国家发热患者(n=3)。
- 多数POCT策略改善临床结局(n=14),其余为临床中性;作者认为尤其高收入和低收入环境中的CRP POCT值得进一步大规模临床评价。
核心结论
- 有证据表明部分POCT在减少抗菌药物处方方面具有成本效果,并可能伴随临床获益。
- 作者认为此类干预——尤其是高收入和低收入环境中的CRP POCT——值得进一步大规模临床评价。
研究设计与样本
- 系统综述,遵循PRISMA指南,在PROSPERO预注册(CRD42022315192)。
- 检索MEDLINE、PubMed、Embase、Cochrane Library和Google Scholar,时间为2000年至2023年。
- 检索策略识别1421项研究,其中20项符合纳入标准。
- 使用卫生经济学标准共识(Consensus of Health Economic Criteria)进行质量评价。
主要发现
- 最常见评估的POCT为呼吸道感染(n=10)、性传播感染(n=3)和中低收入国家发热患者(n=3)。
- 所有研究均从医疗服务提供者视角评估成本;五项额外考虑AMR的社会成本。
- 18项研究识别出减少抗菌药物处方的POCT策略。
- 其中10项研究识别出在每避免一例抗菌药物处方的支付意愿阈值£33.80下具有成本效果的POCT。
- 多数POCT策略改善临床结局(n=14);其余为临床中性。
关键数值与推荐
- 成本效果判定阈值为每避免一例抗菌药物处方的支付意愿£33.80,10项研究在此阈值下认为POCT具有成本效果。
- 18项研究显示POCT策略减少抗菌药物处方。
- 14项研究显示POCT策略改善临床结局,其余为临床中性。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Antimicrobial resistance (AMR) is a major threat to global health. By 2050, it is forecast that AMR will cause 10 million deaths and cost 100 trillion USD annually. Point-of-care tests (POCTs) may represent a cost-effective approach to reduce AMR. OBJECTIVES: We systematically reviewed which POCTs addressing AMR have undergone economic evaluation in primary and secondary healthcare globally, how these POCTs have been economically evaluated, and which are cost-effective in reducing antimicrobial prescribing or the burden of AMR. Clinical cost-effectiveness was additionally addressed. METHODS: This systematic review, accordant with PRISMA guidelines, was pre-registered on PROSPERO (CRD42022315192). MEDLINE, PubMed, Embase, Cochrane Library, and Google Scholar were searched from 2000 to 2023 for relevant publications. Quality assessment was performed using the Consensus of Health Economic Criteria. RESULTS: The search strategy identified 1421 studies, of which 20 met the inclusion criteria. The most common POCTs assessed were for respiratory infections (n = 10), STIs (n = 3), and febrile patients in low- and middle-income countries (n = 3). All studies assessed costs from a healthcare provider perspective; five additionally considered the societal cost of AMR.Eighteen studies identified POCT strategies that reduced antimicrobial prescribing. Of these, 10 identified POCTs that would be considered cost-effective at a willingness-to-pay (WTP) threshold of £33.80 per antibiotic prescription avoided. Most POCT strategies improved clinical outcomes (n = 14); the remainder were clinically neutral. CONCLUSIONS: There is evidence that some POCTs are cost-effective in reducing antimicrobial prescribing, with potential concomitant clinical benefits. Such interventions-especially CRP POCTs in both high- and low-income settings-merit further, large-scale clinical evaluation.
引用
- Tolley A, Bansal A, Murerwa R, et al. Cost-effectiveness of point-of-care diagnostics for AMR: a systematic review. J Antimicrob Chemother. 2024. PMID: 38498622. doi:10.1093/jac/dkae067
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。